90 related articles for article (PubMed ID: 307981)
21. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
Jaffe N; Frei E; Watts H; Traggis D
Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
[No Abstract] [Full Text] [Related]
22. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.
Rosen G; Tefft M; Martinez A; Cham W; Murphy ML
Cancer; 1975 Mar; 35(3):622-30. PubMed ID: 1078640
[TBL] [Abstract][Full Text] [Related]
23. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy of osteogenic sarcoma: progress and perspectives.
Frei E; Jaffe N; Gero M; Skipper H; Watts H
J Natl Cancer Inst; 1978 Jan; 60(1):3-10. PubMed ID: 304894
[No Abstract] [Full Text] [Related]
25. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
26. Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.
Grimes DJ; Bowles MR; Buttsworth JA; Thomson DB; Ravenscroft PJ; Nixon PF; Whiting RF; Pond SM
Drug Saf; 1990; 5(6):447-54. PubMed ID: 2285498
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary treatment for macrometastatic osteogenic sarcoma.
Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
Br Med J; 1976 Oct; 2(6043):1039-41. PubMed ID: 1086696
[TBL] [Abstract][Full Text] [Related]
28. Serum copper investigations in children with acute lymphoblastic leukemia.
Legutko L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):248-54. PubMed ID: 79530
[TBL] [Abstract][Full Text] [Related]
29. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
30. Zinc in human malignancies.
Chakravarty PK; Ghosh A; Chowdhury JR
Neoplasma; 1986; 33(1):85-90. PubMed ID: 3960212
[TBL] [Abstract][Full Text] [Related]
31. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
Jaffe N
Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery.
Rosen G; Huvos AG; Mosende C; Beattie EJ; Exelby PR; Capparos B; Marcove RC
Cancer; 1978 Mar; 41(3):841-9. PubMed ID: 305817
[No Abstract] [Full Text] [Related]
33. Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases.
Rosenburg SA; Flye MW; Conkle D; Seipp CA; Levine AS; Simon RM
Cancer Treat Rep; 1979 May; 63(5):753-6. PubMed ID: 287554
[TBL] [Abstract][Full Text] [Related]
34. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
Cotter SM; Parker LM
Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
[TBL] [Abstract][Full Text] [Related]
35. The treatment of pulmonary metastasis in osteogenic sarcoma.
Marcove RC; Martini N; Rosen G
Clin Orthop Relat Res; 1975 Sep; (111):65-70. PubMed ID: 1080453
[TBL] [Abstract][Full Text] [Related]
36. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
Benjamin R; Helman L; Meyers P; Reaman G
Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
[TBL] [Abstract][Full Text] [Related]
37. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
Catapano MS; Brown JM; Rosenberg SA
Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
[TBL] [Abstract][Full Text] [Related]
38. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
[TBL] [Abstract][Full Text] [Related]
39. The value of serum copper levels in non-Hodgkin's lymphoma.
Cohen Y; Epelbaum R; Haim N; McShan D; Zinder O
Cancer; 1984 Jan; 53(2):296-300. PubMed ID: 6690011
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
Sears HF; Simon R; Rosenberg SA
Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
